HanmiPharm
128940KOSPI🇰🇷Healthcare · Drug Manufacturers - Specialty & Generic
Last updated: 9h ago
52-Week Range
Company Overview
Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare dise
🤖 AI Stock Analysis
📊 Valuation: PER of 54.6x and Forward PER of 33.0x suggest a relatively high valuation, with a PBR of 5.32x indicating a premium to asset value.
💰 Profitability: ROE of 9.9% and ROA of 6.1% show moderate profitability relative to equity and assets, while net profit margin of 7.95% and operating profit margin of 14.42% indicate good profitability from operations.
📈 Growth: Revenue growth is stagnant at 0.1%, but earnings growth is a strong 29.4%, suggesting efficient cost management or increased sales of high-margin products.
💵 Dividend: Dividend yield of 0.25% and payout ratio of 10.88% indicate low dividend attractiveness.
💬 Summary: While the current valuation may be somewhat stretched, the high earnings growth is positive. However, the slowdown in revenue growth warrants consideration for future expansion.
AI-generated reference material. Not investment advice.
Valuation
Profitability
Growth & Stability
Dividends
Trading Info
Related News
[StockHub Alert] Sharp Rise 4
🚀 Sharp Rise • HANWHA SOLUTIONS (009830) ₩51,300 +11.4% • SKSQUARE (402340) ₩603,000 +7.3% • HanmiPharm (128940) ₩531,000 +6.2% • HyundaiMtr (005380) ₩532,500 +5.2%
[StockHub Alert] 52-Week High 1, Sharp Rise 5, Sharp Drop 2
📈 52-Week High • KnJ (272110) ₩39,800 +4.0% 🚀 Sharp Rise • WCP (393890) ₩11,580 +14.3% • HANWHA SOLUTIONS (009830) ₩50,100 +8.8% • HanmiPharm (128940) ₩539,000 +7.8% • SKSQUARE (402340) ₩602,000 +7.1% • HyundaiMtr (005380) ₩537,000 +6.1% 💥 Sharp Drop • Heungu (024060) ₩21,650 -8.1% • MKElectron (033160) ₩15,180 -5.2%